Copyright
©The Author(s) 2016.
World J Gastroenterol. May 7, 2016; 22(17): 4403-4410
Published online May 7, 2016. doi: 10.3748/wjg.v22.i17.4403
Published online May 7, 2016. doi: 10.3748/wjg.v22.i17.4403
Figure 2 Serum Mac-2bp levels were useful for the discrimination of chronic pancreatitis patients from HV subjects and pancreatic ductal adenocarcinoma patients.
A: ROC curve for the discrimination of chronic pancreatitis (CP) patients from HV subjects; B: ROC curve for the discrimination of CP patients from pancreatic ductal adenocarcinoma (PDAC) patients. AUC: Area under the curve; Sen: Sensitivity; Spe: Specificity; PPV: Positive predictive value; NPV: Negative predictive value; Cut-off: Cut-off value.
- Citation: Maekawa T, Kamada Y, Ebisutani Y, Ueda M, Hata T, Kawamoto K, Takamatsu S, Mizutani K, Shimomura M, Sobajima T, Fujii H, Nakayama K, Nishino K, Yamada M, Kumada T, Ito T, Eguchi H, Nagano H, Miyoshi E. Serum Mac-2 binding protein is a novel biomarker for chronic pancreatitis. World J Gastroenterol 2016; 22(17): 4403-4410
- URL: https://www.wjgnet.com/1007-9327/full/v22/i17/4403.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i17.4403